Testing effectiveness (Phase 2)Study completedNCT01609790
What this trial is testing
Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
Who this might be right for
Giant Cell GlioblastomaGlioblastomaGliosarcoma+3 more
National Cancer Institute (NCI) 137